XML 32 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue
9 Months Ended
Sep. 30, 2020
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Disaggregation of Revenue

The Company disaggregates its revenue from contracts with customers by payor source. The Company believes it best depicts how the nature, amount, timing, and uncertainty of its revenue and cash flows are affected by economic factors. See details on a reportable segment basis in the tables below.
Three Months Ended September 30, 2020
(in thousands)Independent LivingAssisted Living and Memory CareCCRCsHealth Care ServicesTotal
Private pay$125,156 $391,292 $57,129 $221 $573,798 
Government reimbursement606 17,403 13,440 71,095 102,544 
Other third-party payor programs— — 5,842 18,587 24,429 
Total resident fee revenue$125,762 $408,695 $76,411 $89,903 $700,771 
Three Months Ended September 30, 2019
(in thousands)Independent LivingAssisted Living and Memory CareCCRCsHealth Care ServicesTotal
Private pay$136,274 $435,367 $70,353 $171 $642,165 
Government reimbursement600 17,107 19,931 89,157 126,795 
Other third-party payor programs— — 9,820 22,457 32,277 
Total resident fee revenue$136,874 $452,474 $100,104 $111,785 $801,237 
Nine Months Ended September 30, 2020
(in thousands)Independent LivingAssisted Living and Memory CareCCRCsHealth Care ServicesTotal
Private pay$390,124 $1,246,181 $181,812 $649 $1,818,766 
Government reimbursement1,778 52,149 46,589 215,350 315,866 
Other third-party payor programs— — 21,582 58,893 80,475 
Total resident fee revenue$391,902 $1,298,330 $249,983 $274,892 $2,215,107 
Nine Months Ended September 30, 2019
(in thousands)Independent LivingAssisted Living and Memory CareCCRCsHealth Care ServicesTotal
Private pay$406,667 $1,310,867 $212,978 $554 $1,931,066 
Government reimbursement1,852 50,358 61,614 269,428 383,252 
Other third-party payor programs— — 30,492 67,769 98,261 
Total resident fee revenue$408,519 $1,361,225 $305,084 $337,751 $2,412,579 
Contract Balances

The payment terms and conditions within the Company's revenue-generating contracts vary by contract type and payor source, although terms generally include payment to be made within 30 days.

Resident fee revenue for recurring and routine monthly services is generally billed monthly in advance under the Company's independent living, assisted living, and memory care residency agreements. Resident fee revenue for standalone or certain healthcare services is generally billed monthly in arrears. A portion of the Company's reimbursement from Medicare for certain healthcare services is billed near the start of each period of care, and cash is generally received before all services are rendered. The amount of revenue recognized for periods of care which are incomplete at period end is based on the Company's historical average percentage of days complete on each period of care and any unearned amounts are deferred and recognized when the service is performed. Additionally, non-refundable community fees are generally billed and collected in advance or upon move-in of a resident under the Company's independent living, assisted living, and memory care residency agreements. Amounts of revenue that are collected from residents in advance are recognized as deferred revenue until the performance obligations are satisfied. The Company had total deferred revenue (included within refundable fees and deferred revenue and other liabilities within the condensed consolidated balance sheets) of $139.5 million and $72.5 million, including $24.2 million and $38.9 million of monthly resident fees billed and received in advance, as of September 30, 2020 and December 31, 2019, respectively. Such amount of total deferred revenue as of September 30, 2020 also included $87.5 million received in the nine months ended September 30, 2020 under a temporary expansion of the Accelerated and Advance Payment Program administered by CMS. Such amount of advance receipts is anticipated to either be recognized as revenue and retained by the Company during the recoupment period from 2021 to 2022 as services are provided or refunded by the Company at the conclusion of such period. Refer to Note 3 for additional information on such program. For the nine months ended September 30, 2020 and 2019, the Company recognized $59.3 million and $83.7 million, respectively, of revenue that was included in the deferred revenue balance as of January 1, 2020 and 2019. The Company applies the practical expedient in ASC 606-10-50-14 and does not disclose amounts for remaining performance obligations that have original expected durations of one year or less.

For the three months ended September 30, 2020 and 2019, the Company recognized $4.8 million and $3.8 million, respectively, and for the nine months ended September 30, 2020 and 2019, the Company recognized $12.4 million and $10.8 million, respectively, of charges within facility operating expense within the condensed consolidated statements of operations for additions to the allowance for credit losses.